$2125 | SAVE $375 | Single User
$4250 | SAVE $750 | Site License
$6375 | SAVE $1,125 | Enterprise License

Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015

Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015
[Lowest Price Guaranteed: $2,125]

Published by Global Data: 23 Dec 2015 | 17882 | In Stock
Related Topics: Clinical Trials

Introduction

Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015" provides an overview of Non-ischemic Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Non-ischemic Cardiomyopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 3

    Report Guidance 4

    Clinical Trials by Region 5

    Clinical Trials and Average Enrollment by Country 6

    Top Countries Contributing to Clinical Trials in Asia-Pacific 9

    Top Five Countries Contributing to Clinical Trials in Europe 10

    Top Countries Contributing to Clinical Trials in North America 11

    Top Countries Contributing to Clinical Trials in Middle East and Africa 12

    Clinical Trials by G7 Countries: Proportion of Non-ischemic Cardiomyopathy to Cardiovascular Clinical Trials 13

    Clinical Trials by Phase in G7 Countries 15

    Clinical Trials in G7 Countries by Trial Status 16

    Clinical Trials by E7 Countries: Proportion of Non-ischemic Cardiomyopathy to Cardiovascular Clinical Trials 17

    Clinical Trials by Phase 18

    In Progress Trials by Phase 19

    Clinical Trials by Trial Status 20

    Clinical Trials by End Point Status 21

    Subjects Recruited Over a Period of Time 22

    Clinical Trials by Sponsor Type 23

    Prominent Sponsors 24

    Top Companies Participating in Non-ischemic Cardiomyopathy Therapeutics Clinical Trials 25

    Prominent Drugs 27

    Clinical Trial Profile Snapshots 28

    Appendix 40

    Abbreviations 40

    Definitions 40

    Research Methodology 41

    Secondary Research 41

    About GlobalData 42

    Contact Us 42

    Disclaimer 42

    Source 43

List Of Tables
in Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015

List of Tables

Non-ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Region, 2015* 5

Non-ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Non-ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2015* 11

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12

Proportion of Non-ischemic Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 14

Non-ischemic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Non-ischemic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Non-ischemic Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 17

Non-ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase, 2015* 18

Non-ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19

Non-ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22

Non-ischemic Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

List Of Figures, Charts and Diagrams
in Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015

List of Figures

Non-ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Region (%), 2015* 5

Non-ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6

Non-ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11

Proportion of Non-ischemic Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 13

Non-ischemic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Non-ischemic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Non-ischemic Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 17

Non-ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18

Non-ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19

Non-ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22

Non-ischemic Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25

Non-ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27

GlobalData Methodology 41

Additional Details

Publisher

Global Data

Publisher Information

Reference

17882 | GDHC3125CTIDB

Number of Pages

43

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2016
The Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010- 2016 report pr...
01 Oct 2016 by Current Partnering USD $2,546 (normally
USD $2,995)
More Info
SAVE 15% today! Allied Healthcare Products, Inc. (AHPI) - Financial and Strategic SWOT Analysis Review
Allied Healthcare Products, Inc. (AHPI) - Financial and Strategic SWOT Analysis Review provides you ...
20 Oct 2015 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! SDI Limited (SDI) - Financial and Strategic SWOT Analysis Review
SDI Limited (SDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic ...
20 Oct 2015 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! Escalon Medical Corp. (ESMC) - Financial and Strategic SWOT Analysis Review
Escalon Medical Corp. (ESMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth...
20 Oct 2015 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! Abcam Plc (ABC) - Financial and Strategic SWOT Analysis Review
Abcam Plc (ABC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SW...
20 Oct 2015 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! ITL Limited (ITD) - Financial and Strategic SWOT Analysis Review
ITL Limited (ITD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic ...
20 Oct 2015 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! Clinical Trial Design for Commercial Success
IntroductionClinical Trial Design for Commercial Success offers expert insights on how to best posit...
01 Jun 2015 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Designing Clinical Trials to Show Value
IntroductionOnce, they were the benchmark for product development. But these days, randomised contro...
01 Jan 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! The Path to Product Inclusion in Clinical Guidelines: Strategies for Success
IntroductionClinical guidelines are taking hold in the practice of medicine. Though not always volun...
01 Feb 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Tapping Social Media for Clinical Trial Recruitment
IntroductionWith an estimated 80% of all clinical trials failing to achieve enrolment goals, sponsor...
01 Apr 2012 by FirstWord Pharma USD $591 (normally
USD $695)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...